Metabolic and biochemical profiling reveals phenotypic heterogeneity in Zucker diabetic fatty rats
Animal Models and Experimental Medicine · 2026-03 · 9 (3) · 442-452
DOI: 10.1002/ame2.70148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, online erschienen am 10.03.2026. Verfasst von Marek Lepáček und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine, Slovak Academy of Sciences, Bratislava, Slovakia. Hauptthemen laut MEDLINE: Obesity, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: VEGA, APVV, Slovak Recovery and Resilience Plan.
Abstract (Originalsprache)
Background
Zucker diabetic fatty (ZDF) rats exhibit significant phenotypic variability despite genetic uniformity, yet a comprehensive characterization of these divergent phenotypes remains limited.
Methods
Male ZDF (fa/fa) rats (4 months, n = 22) and ZDF (fa/+) lean controls ( n = 10) were maintained on standard chow for 6 months. Based on metabolic trajectory, ZDF (fa/fa) rats were stratified into three phenotypes: obese normoglycemic (O, n = 8), diabetic with cachexia (D, n = 8), and diabetic without cachexia (D‐C, n = 6). Comprehensive assessments included body weight, glycemic control, hepatic function, oxidative stress markers, and inflammatory cytokines.
Results
Principal coordinate analysis confirmed significant metabolic separation between phenotypes ( p < 0.01). Diabetic cachectic (D) rats exhibited severe hyperglycemia (>25 mmol/L), insulin depletion, elevated hepatic enzymes (alanine aminotransferase [ALT] increased 2.5‐fold, p < 0.01), elevated interleukin‐6, and delayed pain response. Diabetic rats without cachexia (D‐C) exhibited intermediate hyperglycemia (≈13 mmol/L, p < 0.001 vs. control) with preserved insulin levels, and elevated fibroblast growth factor 21 (FGF21) and soluble receptor for advanced glycation end products (sRAGE). Obese normoglycemic (O) rats maintained normoglycemia with hyperinsulinemia and elevated triglycerides.
Conclusion
Under identical genetic and environmental conditions, ZDF (fa/fa) rats develop distinct metabolic phenotypes encompassing euglycemic obesity, pre‐cachectic diabetes, and advanced cachectic diabetes. Phenotypic stratification is essential for accurate interpretation of ZDF experimental data and underscores the importance of characterizing individual metabolic trajectories when diabetic complications and therapeutic interventions are assessed in this model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine, Slovak Academy of Sciences, Bratislava, Slovakia.
- Institute for Hearth Research, Centre of Experimental Medicine, Slovak Academy of Sciences, Bratislava, Slovakia.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University Bratislava, Bratislava, Slovakia.
ORCID-Profile: Marta Šoltésová Prnová
Förderung
- VEGA
- APVV
- Slovak Recovery and Resilience Plan
- Vedecká Grantová Agentúra MŠVVaŠ SR a SAV
- Agentúra na Podporu Výskumu a Vývoja
Zitieren
APA
Lepáček, M., Boďo, P., Kaločayová, B., & Šoltésová Prnová, M. (2026). Metabolic and biochemical profiling reveals phenotypic heterogeneity in Zucker diabetic fatty rats. Animal Models and Experimental Medicine, 9(3), 442-452. https://doi.org/10.1002/ame2.70148
Vancouver
Lepáček M, Boďo P, Kaločayová B, Šoltésová Prnová M. Metabolic and biochemical profiling reveals phenotypic heterogeneity in Zucker diabetic fatty rats. Animal Models and Experimental Medicine. 2026;9(3):442-452. doi:10.1002/ame2.70148
BibTeX
@article{Lepek2026,
author = {Lepáček, Marek and Boďo, Pavol and Kaločayová, Barbora and Šoltésová Prnová, Marta},
title = {Metabolic and biochemical profiling reveals phenotypic heterogeneity in Zucker diabetic fatty rats},
journal = {Animal Models and Experimental Medicine},
year = {2026},
volume = {9},
number = {3},
pages = {442--452},
doi = {10.1002/ame2.70148}
}
EUVIMED